Crystal structure of the catalytic domain of a human thioredoxin-like protein: Implications for substrate specificity and a novel regulation mechanism

European Journal of Biochemistry

Volumn 269, Issue 8, 2002, Pages 2060-2068

  Jin, Jian ^a,b   Chen, Xuehui ^a   Zhou, Yan ^b   Bartlam, Mark ^a   Guo, Qing ^a   Liu, Yiwei ^a   Sun, Yixin ^a   Gao, Yu ^a,b   Ye, Sheng ^a   Li, Guangtao ^b   Rao, Zihe ^a   Qiang, Boqin ^b   Yuan, Jiangang ^b  

^a TSINGHUA UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Crystal structure; Dithiol oxidoreductase; hTRXL; Monomeric; N terminal

Indexed keywords

THIOREDOXIN;

ARTICLE; BRAIN; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; FETUS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

CATALYTIC DOMAIN; HUMANS; MODELS, MOLECULAR; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; THIOREDOXIN;

EID: 18344386776     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.02844.x     Document Type: Article

References (49)

1. Enzymatic reduction-oxidation of protein disulfides by thioredoxin
2. Thioredoxin
3. Thioredoxin and glutaredoxin systems
4. Enzymatic synthesis of deoxyribonucleotides
5. A specific enzymatic reduction of L(-) methionine sulfoxide and a related non-specific reduction of disulfides
6. Yeast sulfate-reducing systems. I. Reduction of sulfate to sulfite
7. The involvement of the thioredoxin system in the reduction of methionine sulfoxide and sulfate
8. Escherichia coli thioredoxin: A subunit of bacteriophage T7 DNA polymerase
9. Thioredoxin is required for filamentous phage assembly
10. Thioredoxin is the bacterial protein encoded by fip that is required for filamentous bacteriophage f1 assembly
11. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity
12. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
13. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1
14. The effect of H2O2 upon thioredoxin-enriched lens epithelial cells
15. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis
16. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide
17. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism
18. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction
19. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo
20. A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells
21. Thioredoxin redox control of cell growth and death and the effects of inhibitors
22. High-resolution solution structures of oxidized and reduced Escherichia coli thioredoxin
23. Crystal structures of reduced, oxidized, and mutated human thioredoxins: Evidence for a regulatory homodimer
24. The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin
25. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B
26. The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal
27. The role of the redox protein thioredoxin in cell growth and cancer
28. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
29. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR)
30. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide
31. Crystallization and preliminary X-ray analysis of a Trx domain of human thioredoxin-like protein
32. Processing of X-ray diffraction data collected in oscillation mode
33. Crystallography & NMR system: A new software suite for macromolecular structure determination
34. Improved methods for building protein models in electron density maps and the location of errors in these models
35. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities
36. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
37. Raster3d, Version 2.0. A program for photorealistic molecular graphics
38. Molecular cloning and expression of a cDNA encoding a human thioredoxin-like protein
39. Purification, molecular cloning, and characterization of TRP32, a novel thioredoxin-related mammalian protein of 32 kDa
40. Protein disulphide-isomerase: A homologue of thioredoxin implicated in the biosynthesis of secretory proteins
41. Structure of NF-kappa B p50 homodimer bound to a kappa B site
42. Structure of the NF-kappa B p50 homodimer bound to DNA
43. Substitution of the conserved tryptophan 31 in Escherichia coli thioredoxin by site-directed mutagenesis and structure-function analysis
44. Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione
45. Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction
46. JPred: A consensus secondary structure prediction server
47. Evaluation and improvement of multiple sequence methods for protein secondary structure prediction
48. FORESST: Fold recognition from secondary structure predictions of proteins
49. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 Å